Skip to Content

2 Results Found

  • Article
  • Open Access
4 Citations
3,597 Views
10 Pages

Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction

  • Shintaro Maki,
  • Ineko Kato,
  • Naosuke Enomoto,
  • Sho Takakura and ,
  • Masafumi Nii,
  • Kayo Tanaka,
  • Hiroaki Tanaka,
  • Shinsuke Hori,
  • Kana Matsuda and
  • Tomoaki Ikeda
  • + 9 authors+ 4 authors

To assess the long-term effects of tadalafil, a therapeutic agent for fetal growth restriction (FGR), we evaluated the developmental progress of 1.5-year-old infants whose mothers had taken tadalafil during pregnancy. Twenty-four infants were assesse...

(This article belongs to the Special Issue The Prevention and Treatment of Preeclampsia and Fetal Growth Restriction)
  • Article
  • Open Access
5 Citations
2,991 Views
13 Pages

Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction

  • Makoto Tsuji,
  • Shintaro Maki,
  • Naosuke Enomoto,
  • Kota Okamoto and ,
  • Asa Kitamura,
  • Shoichi Magawa,
  • Sho Takakura,
  • Masafumi Nii,
  • Kayo Tanaka and
  • Tomoaki Ikeda
  • + 10 authors+ 5 authors

Background and Objectives: Tadalafil is expected to treat fetal growth restriction (FGR), a risk factor for stillbirth and neonatal morbidity. This study aimed to evaluate the fetal biometric growth pattern of fetuses with FGR treated with tadalafil...

(This article belongs to the Section Obstetrics and Gynecology)